Status: current, Primitive. Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3943874011 | Rimegepant | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3943875012 | Rimegepant (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rimegepant | Is a | Pyridine | true | Inferred relationship | Some | ||
| Rimegepant | Has disposition | Calcitonin gene-related peptide receptor antagonist | true | Inferred relationship | Some | ||
| Rimegepant | Is a | Calcitonin gene-related peptide receptor antagonist | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Rimegepant-containing product | Has active ingredient | True | Rimegepant | Inferred relationship | Some | 1 |
| Rimegepant only product | Has active ingredient | True | Rimegepant | Inferred relationship | Some | 1 |
| Rimegepant only product in oral dose form | Has active ingredient | True | Rimegepant | Inferred relationship | Some | 1 |
| Rimegepant-containing product in oral dose form | Has active ingredient | True | Rimegepant | Inferred relationship | Some | 1 |
| Rimegepant sulfate | Is modification of | True | Rimegepant | Inferred relationship | Some | |
| Rimegepant (as rimegepant sulfate) 75 mg orodispersible tablet | Has BoSS | True | Rimegepant | Inferred relationship | Some | 1 |
| Rimegepant-containing product in oromucosal dose form | Has active ingredient | True | Rimegepant | Inferred relationship | Some | 1 |
| Rimegepant only product in oromucosal dose form | Has active ingredient | True | Rimegepant | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR